Correlation Between Mrna Expression, Promoter Methylation Of Mgmt Gene And Risk Of Esophageal Cancer

Liu Ran,Liang Ge-Yu,Yin Li-Hong,Pu Yue-Pu,Wang Yi,Pan En-Chun,Wang Yi,Pan En-Chun

2007-01-01

Abstract:To evaluate whether expression level and promoter methylation of O-6 - methylguanine - DNA methyltranspherase (MGMT) gene is associated with the risk for ESCC, 91 patients with newly diagnosed, untreated esophageal cancer were recruited in the present study. Esophageal cancer tissues and tissues adjacent to the tumors were collected to determine mRNA level and CpG island hypermethylation of promoter. Expression levels of MGMT gene were measured by quantitative real - time reverse transcription - PCR. And methylation specific PCR (MSP) was used to examine the methylation status of MGMT gene. Analysis of variance (ANOVA), Chi - square test, and logistic regression analysis were used to determine the association of each characteristic with the risk for esophageal cancer in esophagus tissues. Compared with tissues adjacent to the tumors, the relative expression levels of MGMT was significantly altered in esophageal cancer tissues. The conditional logistic regression analysis exhibited that the increased risk for esophageal cancer were significantly associated with aberrant expression of MGMT (OR = 1.311, 95% CI: 1.041 similar to 1.65 1). And hypermethylation of MGMT gene in carcinoma tissues was significantly different from that in tissues adjacent to the tumors (OR = 7.750, 95% CI = 2.736 similar to 21.955). There was no significant correlation between methylation status and mRNA. level. This study suggests that reduced expression of mRNA and CpG island hypermethylation of MGMT gene are associated with an enhanced risk for ESCC. But the relationship between methylation status and mRNA level on function of MGMT gene is not confirmed.